This inventor holds 2 USPTO granted patents. Top assignee: Liplasome Pharma A/s. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ringsted, DK (2007)
- Holte, DK (2008)
Company Filing History:
Years Active: 2007-2008
Title: Charlotte Vermehren: Innovator in Lipid-Based Drug Delivery Systems
Introduction
Charlotte Vermehren is a prominent inventor based in Holte, Denmark. She has made significant contributions to the field of lipid-based drug delivery systems, focusing on innovative solutions for targeting diagnostic agents and treating parasitic infections. With a total of 2 patents, her work is paving the way for advancements in medical diagnostics and therapeutics.
Latest Patents
Charlotte's latest patents include two groundbreaking inventions. The first patent, titled "Lipid-based systems for targeting diagnostic agents," relates to the use of lipid-based compositions for the targeted delivery of diagnostic agents. This invention is particularly useful in diagnosing various disorders associated with increased levels of extracellular phospholipase A (PLA) activity in diseased tissues, such as cancer, infectious diseases, and inflammatory conditions. The second patent, "Lipid-based drug delivery systems against parasitic infections," focuses on a lipid-based delivery system for administering active drug substances derived from lysolipid derivatives. This system is especially beneficial in treating or detecting parasitic infections that elevate PLA levels in infected mammals, particularly those involving the liver and spleen.
Career Highlights
Charlotte Vermehren is currently associated with Liplasome Pharma A/S, where she continues to innovate in the field of drug delivery systems. Her expertise and dedication to research have positioned her as a key player in the pharmaceutical industry.
Collaborations
Charlotte collaborates with notable colleagues, including Kent Jørgensen and Jesper Davidsen, who contribute to her research endeavors and the advancement of lipid-based therapies.
Conclusion
Charlotte Vermehren's work in lipid-based drug delivery systems exemplifies her commitment to improving medical diagnostics and treatment options. Her innovative patents and collaborations highlight her significant impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile